首页> 美国卫生研究院文献>Journal of the Boston Society of Medical Sciences >The Leukocyte Semaphorin CD100 Is Expressed in Most T-Cell but Few B-Cell Non-Hodgkin’s Lymphomas
【2h】

The Leukocyte Semaphorin CD100 Is Expressed in Most T-Cell but Few B-Cell Non-Hodgkin’s Lymphomas

机译:白细胞信号蛋白CD100在大多数T细胞中表达但很少有B细胞非霍奇金淋巴瘤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The 150-kd transmembrane protein CD100 is the first semaphorin protein shown to be expressed in lymphoid tissue. CD100 is present in the interfollicular T cell zones and is also expressed by B cells in the germinal centers of secondary lymphoid follicles, but not in the mantle zones. The CD100 molecule was recently cloned, and CD100 transfectants were shown to induce homotypic aggregation of human B cells and improve their viability in vitro, suggesting that CD100 may play a role in lymphocyte aggregation and germinal center formation. We studied the expression of CD100 in 138 clinical cases representing a range of lymphoproliferative disorders, to determine whether this molecule is expressed in these neoplastic processes. In general, we found CD100 expression to be common in peripheral T-cell non-Hodgkin’s lymphomas but rare in B-cell non-Hodgkin’s lymphomas. CD100 expression was not detectable in low-grade B-cell non-Hodgkin’s lymphomas, including cases of small lymphocytic lymphoma (18 cases), marginal zone lymphoma (10 cases), and mantle cell lymphoma (10 cases), as might be expected for these neoplasms that are not of follicular center cell origin. Surprisingly, we found that the vast majority of follicular lymphomas (37 of 40 cases) as well as diffuse large-cell lymphomas of B-cell type (35 cases) did not express CD100. The neoplastic cells in 3 of 11 cases of predominantly large-cell-type follicular lymphoma did express CD100. In contrast, all five cases of high-grade, small non-cleaved (Burkitt-like) B-cell lymphoma were immunoreactive for CD100 expression, as were 18 of 20 cases (90%) of malignant T cell neoplasms. Northern blot analysis of CD100 expression correlated with immunohistochemical findings. Absence of expression of CD100 by neoplastic follicular center B cells is a common feature in follicular lymphomas, but expression of CD100 by T cells is maintained in T-cell lymphoproliferative disorders.
机译:150 kd跨膜蛋白CD100是显示在淋巴样组织中表达的第一种信号蛋白。 CD100存在于小泡间T细胞区,并在次级淋巴滤泡的生发中心由B细胞表达,但在地幔区不表达。最近克隆了CD100分子,并显示CD100转染子可诱导人B细胞同型聚集并提高其体外存活力,这表明CD100可能在淋巴细胞聚集和生发中心形成中起作用。我们研究了代表一系列淋巴增生性疾病的138例临床病例中CD100的表达,以确定该分子是否在这些肿瘤过程中表达。总的来说,我们发现CD100表达在周围性T细胞非霍奇金淋巴瘤中很常见,但在B细胞非霍奇金淋巴瘤中很罕见。在低级B细胞非霍奇金淋巴瘤中检测不到CD100表达,包括小淋巴细胞淋巴瘤(18例),边缘区淋巴瘤(10例)和套细胞淋巴瘤(10例)。这些不是滤泡中心细胞起源的肿瘤。令人惊讶地,我们发现绝大多数滤泡性淋巴瘤(40例中的37例)以及B细胞型弥漫性大细胞淋巴瘤(35例)不表达CD100。在11例主要为大细胞型滤泡性淋巴瘤的病例中,有3例的肿瘤细胞确实表达了CD100。相比之下,所有5例高级别,小的未切割(伯基特样)B细胞淋巴瘤均对CD100表达具有免疫反应性,在20例恶性T细胞肿瘤中,有18例(90%)是免疫反应性的。 CD100表达的Northern印迹分析与免疫组化结果相关。滤泡性淋巴瘤B细胞不表达CD100是滤泡性淋巴瘤的常见特征,但T细胞淋巴增生性疾病可维持T细胞表达CD100。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号